Condition 1: Radiation acute dermatitis. Condition 2: Breast cancer. Irritant contact dermatitis Malignant neoplasm of breast
Conditions
Interventions
Intervention 1: Chamomile extract is prescribed in the Basic Cold Cream, 4% in the cream, 3 times a day on the first day of radiation therapy to radiation treatment two weeks after. Intervention 2: Co
Prevention
Chamomile extract is prescribed in the Basic Cold Cream, 4% in the cream, 3 times a day on the first day of radiation therapy to radiation treatment two weeks after
Control: placebo administered in combination with the base color and allowed Cold Cream orally 3 times a day on the first day of radiation therapy to radiation treatment two weeks after
Sponsors
Vice chancellor for research, Ahwaz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria; Adults over 18 years; breast cancer diagnosis in a Syth is approved by the oncologist; Patients who underwent a radical mastectomy and breast have been; Not having a mental illness; not using the drug topically on affected area of acute dermatitis; a chronic skin disease such as pemphigus and no collagen vascular disease; the disease weakens the immune system; a lack of diabetes; Old burn scars in the area of radiation; no use in patients bolus; not receiving concurrent chemotherapy with radiation; the lack of sensitivity to drug testing patch; 5000 cGy total dose of radiation; the depth of the cm 7.5-9.5; mass physical between 19.8 to 26; is able to communicate out of this situation; not wanting to continue the intervention; surgery, infection and bleeding at the time of the study; the incidence of drug allergy
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intensity of radiation acute dermatitis. Timepoint: 3, 6, 9, 12, 15, 18, 21, 24 days and 2 week after completion of treatment. Method of measurement: RTOG criteria based on measurements that can be graded from 0 to 4. | — |
Secondary
| Measure | Time frame |
|---|---|
| Drug allergy. Timepoint: During treatment. Method of measurement: Czech list. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Jourkesh
University of Medical Sciences
Outcome results
None listed